These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 28396950

  • 1. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H.
    Eur Spine J; 2017 May; 26(Suppl 1):236-242. PubMed ID: 28396950
    [Abstract] [Full Text] [Related]

  • 2. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
    Duan PG, Sheng YH, Deng CH, Tang BY, Yao HQ.
    BMC Musculoskelet Disord; 2020 Feb 15; 21(1):105. PubMed ID: 32061254
    [Abstract] [Full Text] [Related]

  • 3. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report.
    Zhang Y, Ilaslan H, Krishnaney AA, Bauer TW.
    JBJS Case Connect; 2016 Feb 15; 6(3):e74. PubMed ID: 29252651
    [Abstract] [Full Text] [Related]

  • 4. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report.
    Kinoshita H, Orita S, Yonemoto T, Ishii T, Iwata S, Kamoda H, Tsukanishi T, Inage K, Abe K, Inoue M, Norimoto M, Umimura T, Fujimoto K, Shiga Y, Kanamoto H, Furuya T, Takahashi K, Ohtori S.
    J Med Case Rep; 2019 Apr 26; 13(1):116. PubMed ID: 31023361
    [Abstract] [Full Text] [Related]

  • 5. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE.
    Spine J; 2024 Jun 26; 24(6):1056-1064. PubMed ID: 38301904
    [Abstract] [Full Text] [Related]

  • 6. Morphologic Changes After Denosumab Therapy in Patients with Giant Cell Tumor of the Spine: Report of Four Cases and a Review of the Literature.
    Yonezawa N, Murakami H, Demura S, Kato S, Yoshioka K, Takeuchi A, Shinmura K, Yokogawa N, Shimizu T, Oku N, Kitagawa R, Handa M, Tsuchiya H.
    World Neurosurg; 2019 Jul 26; 127():38-46. PubMed ID: 30926552
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of denosumab in joint preservation for patients with giant cell tumour of the bone.
    Traub F, Singh J, Dickson BC, Leung S, Mohankumar R, Blackstein ME, Razak AR, Griffin AM, Ferguson PC, Wunder JS.
    Eur J Cancer; 2016 May 26; 59():1-12. PubMed ID: 26990281
    [Abstract] [Full Text] [Related]

  • 8. Recommencement of Denosumab for Unresectable Giant Cell Tumor of the Cervical Spine: A Case Report.
    Law GW, Yeo NEM, Howe TS, Tan YZ, Tan SB, Siddiqui MMA.
    Spine (Phila Pa 1976); 2018 May 01; 43(9):E551-E556. PubMed ID: 29016442
    [Abstract] [Full Text] [Related]

  • 9. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone.
    Branstetter DG, Nelson SD, Manivel JC, Blay JY, Chawla S, Thomas DM, Jun S, Jacobs I.
    Clin Cancer Res; 2012 Aug 15; 18(16):4415-24. PubMed ID: 22711702
    [Abstract] [Full Text] [Related]

  • 10. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
    Tang Q, Lu J, Zhu X, Song G, Wu H, Xu H, Wang A, Wang J.
    Eur Spine J; 2023 Dec 15; 32(12):4297-4305. PubMed ID: 37318598
    [Abstract] [Full Text] [Related]

  • 11. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E.
    Spine J; 2014 Jul 01; 14(7):e15-21. PubMed ID: 24534393
    [Abstract] [Full Text] [Related]

  • 12. [Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].
    Sørensen AL, Hansen RL, Jørgensen PH.
    Ugeskr Laeger; 2016 Sep 05; 178(36):. PubMed ID: 27593237
    [Abstract] [Full Text] [Related]

  • 13. Primary thoracic giant cell tumor of bone sensitive to steroids.
    Yang H, Im GH, Nielsen GP, Kheterpal A, Schwab JH.
    Skeletal Radiol; 2018 Oct 05; 47(10):1431-1435. PubMed ID: 29502130
    [Abstract] [Full Text] [Related]

  • 14. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E, Chawla NS, Ferrari S, Sudan M, Picci P, Marchesi E, Leopardi MP, Syed I, Sankhala KK, Parthasarathy P, Mendanha WE, Pierini M, Paioli A, Chawla SP.
    Eur J Cancer; 2017 May 05; 76():118-124. PubMed ID: 28324746
    [Abstract] [Full Text] [Related]

  • 15. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
    Bukata SV, Blay JY, Rutkowski P, Skubitz K, Henshaw R, Seeger L, Dai T, Jandial D, Chawla S.
    Spine (Phila Pa 1976); 2021 Mar 01; 46(5):277-284. PubMed ID: 33038190
    [Abstract] [Full Text] [Related]

  • 16. A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab.
    Mak IW, Evaniew N, Popovic S, Tozer R, Ghert M.
    J Bone Joint Surg Am; 2014 Aug 06; 96(15):e127. PubMed ID: 25100780
    [Abstract] [Full Text] [Related]

  • 17. Can Denosumab cure giant cell tumors of the spine? A case report and literature review.
    Xará-Leite F, Coutinho L, Fleming C, Magalhães M, Oliveira V, Rodrigues-Pinto R, Cardoso P.
    Eur J Orthop Surg Traumatol; 2020 Jan 06; 30(1):19-23. PubMed ID: 31529151
    [Abstract] [Full Text] [Related]

  • 18. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
    Sano K, Suehara Y, Okubo T, Sasa K, Kurihara T, Akaike K, Kubota D, Torigoe T, Hasegawa N, Ishii M, Nakamura Y, Kim Y, Takagi T, Kaneko K, Hayashi T, Saito T.
    J Orthop Surg (Hong Kong); 2020 Jan 06; 28(2):2309499020929786. PubMed ID: 32539628
    [Abstract] [Full Text] [Related]

  • 19. Spectrum of histological features of Denosumab treated Giant Cell Tumor of Bone; potential pitfalls and diagnostic challenges for pathologists.
    Tariq MU, Umer M, Khan Z, Saeed J, Siddiqui MA, Din NU.
    Ann Diagn Pathol; 2020 Apr 06; 45():151479. PubMed ID: 32088577
    [Abstract] [Full Text] [Related]

  • 20. Denosumab treated giant cell tumour of bone: a morphological, immunohistochemical and molecular analysis of a series.
    Girolami I, Mancini I, Simoni A, Baldi GG, Simi L, Campanacci D, Beltrami G, Scoccianti G, D'Arienzo A, Capanna R, Franchi A.
    J Clin Pathol; 2016 Mar 06; 69(3):240-7. PubMed ID: 26338802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.